{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:18:41Z","timestamp":1792801121853,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156519"],"award-info":[{"award-number":["1156519"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.autrev.2023.103499","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:02:27Z","timestamp":1701799347000},"page":"103499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review"],"prefix":"10.1016","volume":"23","author":[{"given":"Pakeeran","family":"Siriratnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilija","family":"Jokubaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2023.103499_bb0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.autrev.2023.103499_bb0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.autrev.2023.103499_bb0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3988\/jcn.2022.18.4.453","article-title":"Disease course and outcomes in patients with the limited form of neuromyelitis optica spectrum disorders and negative AQP4-IgG serology at disease onset: a prospective cohort study","volume":"18","author":"Chen","year":"2022","journal-title":"J Clin Neurol"},{"issue":"Pt 6","key":"10.1016\/j.autrev.2023.103499_bb0025","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.autrev.2023.103499_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/18756190MTA2cMjAm1","article-title":"Anti-IL-6 therapies for neuromyelitis optica spectrum disorders: a systematic review of safety and efficacy","volume":"19","author":"Lotan","year":"2021","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103499_bb0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.autrev.2023.103499_bb0050","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N Engl J Med"},{"issue":"10206","key":"10.1016\/j.autrev.2023.103499_bb0055","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","article-title":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial","volume":"394","author":"Cree","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103499_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.933415","article-title":"Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: how it influences clinical course, MRI parameters and prognosis","volume":"13","author":"Nytrova","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103499_bb0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2018.00611","article-title":"Gender bias in human systemic lupus erythematosus: a problem of steroid receptor action?","volume":"9","author":"Rider","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103499_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.737673","article-title":"A comprehensive review on the role of genetic factors in neuromyelitis optica spectrum disorder","volume":"12","author":"Ghafouri-Fard","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13167-018-0143-9","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies","volume":"9","author":"Borisow","year":"2018","journal-title":"EPMA J"},{"key":"10.1016\/j.autrev.2023.103499_bb0085","doi-asserted-by":"crossref","first-page":"103465","DOI":"10.1016\/j.autrev.2023.103465","article-title":"A comprehensive review of the advances in neuromyelitis optica spectrum disorder","author":"Siriratnam","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41582-020-0313-y","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations","volume":"16","author":"Mao-Draayer","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/13524585221130934","article-title":"Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French multiple sclerosis society","volume":"29","author":"Vukusic","year":"2023","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jnnp-2020-323982","article-title":"Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors","volume":"92","author":"Wang","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0105","first-page":"499","article-title":"Is human fecundity changing? A discussion of research and data gaps precluding us from having an answer","volume":"32","author":"Smarr","year":"2017","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(00)00604-X","article-title":"Infertility is a symptom, not a disease","volume":"74","author":"Dickey","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.autrev.2023.103499_bb0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2393-14-75","article-title":"Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study","volume":"14","author":"Kersten","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.autrev.2023.103499_bb0120","series-title":"Reproductive and perinatal epidemiology","first-page":"340","volume":"vol. xiii","author":"Louis","year":"2011"},{"key":"10.1016\/j.autrev.2023.103499_bb0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.rbms.2019.11.002","article-title":"A wonderful experience or a frightening commitment? An exploration of men\u2019s reasons to (not) have children","volume":"9","author":"Bodin","year":"2019","journal-title":"Reprod Biomed Soc Online"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0130","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000339","article-title":"Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study","volume":"4","author":"Bove","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"14","key":"10.1016\/j.autrev.2023.103499_bb0135","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1177\/1352458517740215","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: interactions and management","volume":"23","author":"Shosha","year":"2017","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.autrev.2023.103499_bb0140","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2023.103499_bb0145","doi-asserted-by":"crossref","first-page":"1048502","DOI":"10.3389\/fneur.2022.1048502","article-title":"Pregnancy and antibody-mediated CNS disorders: what do we know and what should we know?","volume":"13","author":"Cortese","year":"2022","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0150","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.fertnstert.2008.07.1785","article-title":"Aquaporin-4 deficiency induces subfertility in female mice","volume":"92","author":"Sun","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2006.12.040","article-title":"Aquaporin 4 regulates the effects of ovarian hormones on monoamine neurotransmission","volume":"353","author":"Sun","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/molehr\/gaaa007","article-title":"Uterine aquaporin expression is dynamically regulated by estradiol and progesterone and ovarian stimulation disrupts embryo implantation without affecting luminal closure","volume":"26","author":"de Oliveira","year":"2020","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10815-015-0615-y","article-title":"The anti-Mullerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH","volume":"33","author":"Sacchi","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.autrev.2023.103499_bb0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fneur.2018.00446","article-title":"Ovarian reserve in women with neuromyelitis optica spectrum disorder","volume":"9","author":"Thone","year":"2018","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103499_bb0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/1352458515602339","article-title":"Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: a pilot study","volume":"22","author":"Sepulveda","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1352458514540843","article-title":"Serum anti-Mullerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis","volume":"21","author":"Thone","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103499_bb0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-11-60","article-title":"Anti-Mullerian-hormone levels during pregnancy and postpartum","volume":"11","author":"Koninger","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12902-020-00569-6","article-title":"Role of anti-Mullerian hormone and testosterone in follicular growth: a cross-sectional study","volume":"20","author":"Lv","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.autrev.2023.103499_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0200","first-page":"99","article-title":"Age and fertility: a study on patient awareness","volume":"20","author":"Deatsman","year":"2016","journal-title":"JBRA Assist Reprod"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0974-1208.74152","article-title":"Fertility and age","volume":"3","author":"George","year":"2010","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","article-title":"Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"86","author":"Nour","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0215","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41467-018-04332-3","article-title":"A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica","volume":"9","author":"Estrada","year":"2018","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.autrev.2023.103499_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019797","article-title":"Maternal and fetal complications associated with systemic lupus erythematosus: an updated meta-analysis of the most recent studies (2017-2019)","volume":"99","author":"He","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2023.103499_bb0225","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000288","article-title":"Immunology of neuromyelitis optica during pregnancy","volume":"3","author":"Davoudi","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.autrev.2023.103499_bb0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25438","article-title":"Analysis of pregnancy-related attacks in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.autrev.2023.103499_bb0235","article-title":"Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12884-021-03682-z","article-title":"Prevalence and clinical, social, and health care predictors of miscarriage","volume":"21","author":"Strumpf","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000101","article-title":"Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study","volume":"1","author":"Roberts","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2023.103499_bb0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12887-015-0362-3","article-title":"Still births, neonatal deaths and neonatal near miss cases attributable to severe obstetric complications: a prospective cohort study in two referral hospitals in Uganda","volume":"15","author":"Nakimuli","year":"2015","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.autrev.2023.103499_bb0255","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-3016.2008.00971.x","article-title":"The prevalence of preterm birth and season of conception","volume":"22","author":"Bodnar","year":"2008","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0260","first-page":"813","article-title":"Down-regulation of aquaporin 4 in human placenta throughout pregnancy","volume":"21","author":"De Falco","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.autrev.2023.103499_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104760","article-title":"A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)","volume":"75","author":"Leite","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103499_bb0270","series-title":"Miscarriage","author":"Dugas","year":"2023"},{"issue":"6","key":"10.1016\/j.autrev.2023.103499_bb0275","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","article-title":"Neuromyelitis optica IgG causes placental inflammation and fetal death","volume":"191","author":"Saadoun","year":"2013","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.autrev.2023.103499_bb0280","doi-asserted-by":"crossref","first-page":"e2006","DOI":"10.1212\/WNL.0000000000011744","article-title":"Pregnancy in patients with AQP4-Ab, MOG-Ab, or double-negative neuromyelitis optica disorder","volume":"96","author":"Collongues","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103499_bb0290","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/1352458513498125","article-title":"Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum","volume":"19","author":"Ringelstein","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103499_bb0295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2172-11-59","article-title":"Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array","volume":"11","author":"Szarka","year":"2010","journal-title":"BMC Immunol"},{"issue":"16","key":"10.1016\/j.autrev.2023.103499_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168946","article-title":"Th17-related cytokines as potential discriminatory markers between neuromyelitis optica (Devic\u2019s disease) and multiple sclerosis-a review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103499_bb0305","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cca.2019.12.013","article-title":"Changes of serum interleukin-6 in healthy pregnant women and establishment of relevant reference intervals","volume":"502","author":"Fu","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0310","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jri.2009.12.003","article-title":"Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients","volume":"84","author":"Wang","year":"2010","journal-title":"J Reprod Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103499_bb0315","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0320","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12884-021-04158-w","article-title":"Prediction of miscarriage in first trimester by serum estradiol, progesterone and beta-human chorionic gonadotropin within 9 weeks of gestation","volume":"22","author":"Deng","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20080521","article-title":"Estrogen directly activates AID transcription and function","volume":"206","author":"Pauklin","year":"2009","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0330","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1515\/CCLM.2010.127","article-title":"Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders","volume":"48","author":"Jarius","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0335","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.immuni.2015.10.002","article-title":"Activation-induced cytidine deaminase expression in human B cell precursors is essential for central B cell tolerance","volume":"43","author":"Cantaert","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.23741","article-title":"Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody","volume":"73","author":"Tradtrantip","year":"2013","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103499_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072099","article-title":"B regulatory cells: players in pregnancy and early life","volume":"19","author":"Esteve-Sole","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2023.103499_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","article-title":"Estrogen receptor profiles in human peripheral blood lymphocytes","volume":"132","author":"Pierdominici","year":"2010","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0355","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.15790","article-title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis","volume":"185","author":"Socie","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0360","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0365","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000913","article-title":"Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany","volume":"8","author":"Kumpfel","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0370","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0375","article-title":"Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series","volume":"5","author":"Perrotta","year":"2021","journal-title":"Rheumatol Adv Pract"},{"issue":"9","key":"10.1016\/j.autrev.2023.103499_bb0380","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/rheumatology\/kev405","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part II: analgesics and other drugs used in rheumatology practice","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0385","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2023.103499_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102525","article-title":"In utero exposure to azathioprine in autoimmune disease. Where do we stand?","volume":"19","author":"Belizna","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0395","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103499_bb0400","article-title":"Pregnancy and neuromyelitis optica spectrum disorder - reciprocal effects and practical recommendations: a systematic review","volume":"11","author":"D\u2019Souza","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0405","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes","volume":"43","author":"Bandoli","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2023.103499_bb0410","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.reprotox.2017.02.006","article-title":"The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis","volume":"69","author":"Xiao","year":"2017","journal-title":"Reprod Toxicol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103499_bb0415","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/ene.14274","article-title":"Outcome of pregnancies after onset of the neuromyelitis optica spectrum disorder","volume":"27","author":"Kim","year":"2020","journal-title":"Eur J Neurol"},{"issue":"16","key":"10.1016\/j.autrev.2023.103499_bb0420","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","article-title":"Influence of pregnancy on neuromyelitis optica spectrum disorder","volume":"78","author":"Kim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103499_bb0425","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2147\/IJWH.S283216","article-title":"Management of pregnancy in women of advanced maternal age: improving outcomes for mother and baby","volume":"13","author":"Glick","year":"2021","journal-title":"Int J Womens Health"},{"issue":"9","key":"10.1016\/j.autrev.2023.103499_bb0430","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/jnnp-2022-330533","article-title":"Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis","volume":"94","author":"Schubert","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.autrev.2023.103499_bb0435","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000903","article-title":"Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab","volume":"7","author":"Razaz","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.autrev.2023.103499_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222343","article-title":"Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia","volume":"14","author":"Shaharir","year":"2019","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.autrev.2023.103499_bb0445","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103499_bb0450","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","article-title":"Neuromyelitis optica and pregnancy","volume":"78","author":"Bourre","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.autrev.2023.103499_bb0455","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/1352458515583376","article-title":"Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder","volume":"22","author":"Shimizu","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103499_bb0460","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.msard.2018.07.006","article-title":"Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"25","author":"Tong","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.autrev.2023.103499_bb0465","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamaneurol.2019.4173","article-title":"Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis","volume":"77","author":"Krysko","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103499_bb0470","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/acn3.51683","article-title":"Effects of pregnancy on neuromyelitis optica spectrum disorder and predictors of related attacks","volume":"9","author":"Du","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"22","key":"10.1016\/j.autrev.2023.103499_bb0475","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1212\/WNL.0000000000004681","article-title":"High risk of postpartum relapses in neuromyelitis optica spectrum disorder","volume":"89","author":"Klawiter","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103499_bb0480","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cen3.12156","article-title":"Relapse of neuromyelitis optica during pregnancy: transition of the anti-aquaporin 4 antibodies titer","volume":"6","author":"Hiromasa Toji","year":"2014","journal-title":"Clin Exp Neuroimmunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0485","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12884-016-0937-5","article-title":"Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study","volume":"16","author":"Schock","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.autrev.2023.103499_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0495","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1096\/fj.04-1901hyp","article-title":"Pregnancy-induced up-regulation of aquaporin-4 protein in brain and its role in eclampsia","volume":"19","author":"Quick","year":"2005","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.autrev.2023.103499_bb0500","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaneurol.2013.3124","article-title":"Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica","volume":"70","author":"Matiello","year":"2013","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0505","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2009.304","article-title":"Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis","volume":"67","author":"Langer-Gould","year":"2010","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103499_bb0510","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.dld.2013.02.001","article-title":"Update on pregnancy and breastfeeding in the era of biologics","volume":"45","author":"Yarur","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.autrev.2023.103499_bb0515","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.autrev.2023.103499_bb0520","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/rheumatology\/key091","article-title":"Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study","volume":"57","author":"Saito","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2023.103499_bb0525","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/rheumatology\/kex039","article-title":"Low level of rituximab in human breast milk in a patient treated during lactation","volume":"56","author":"Bragnes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2023.103499_bb0530","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/bfm.2014.0107","article-title":"Lactation and the use of biologic immunosuppressive medications","volume":"9","author":"Witzel","year":"2014","journal-title":"Breastfeed Med"},{"issue":"11","key":"10.1016\/j.autrev.2023.103499_bb0535","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/acn3.51893","article-title":"Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions","volume":"10","author":"Anderson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2023.103499_bb0540","doi-asserted-by":"crossref","first-page":"1090133","DOI":"10.3389\/fneur.2022.1090133","article-title":"The protective role of breastfeeding in multiple sclerosis: latest evidence and practical considerations","volume":"13","author":"Collorone","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103499_bb0545","first-page":"1","article-title":"Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis","volume":"0","author":"Haben","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2023.103499_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562864211009104","article-title":"The MSBase pregnancy, neonatal outcomes, and women\u2019s health registry","volume":"14","author":"Jokubaitis","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"10.1016\/j.autrev.2023.103499_bb0555","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-020-09699-2","article-title":"Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort","volume":"267","author":"Carnero Contentti","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0560","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41598-022-04836-5","article-title":"Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France","volume":"12","author":"Gbaguidi","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0565","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10067-016-3478-4","article-title":"Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus","volume":"36","author":"Sassi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103499_bb0570","doi-asserted-by":"crossref","first-page":"1037812","DOI":"10.3389\/fimmu.2022.1037812","article-title":"Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder","volume":"13","author":"Bauer","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0575","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J"},{"issue":"7","key":"10.1016\/j.autrev.2023.103499_bb0580","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2023.103499_bb0585","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fneur.2019.01070","article-title":"Pregnancy-related immune changes and demyelinating diseases of the central nervous system","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103499_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907994","article-title":"Alterations of NK cell phenotype during pregnancy in multiple sclerosis","volume":"13","author":"Wisgalla","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103499_bb0595","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0897.2011.00978.x","article-title":"High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus","volume":"66","author":"Torricelli","year":"2011","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103499_bb0600","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00415-015-7663-1","article-title":"Fecundity in women with multiple sclerosis: an observational mono-centric study","volume":"262","author":"Roux","year":"2015","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103499_bb0605","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000840","article-title":"Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology","volume":"9","author":"Stamm","year":"2022","journal-title":"Lupus Sci Med"},{"issue":"22","key":"10.1016\/j.autrev.2023.103499_bb0610","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1212\/WNL.0b013e3181c3f27d","article-title":"Obstetric outcomes in women with multiple sclerosis and epilepsy","volume":"73","author":"Kelly","year":"2009","journal-title":"Neurology"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:31:21Z","timestamp":1761600681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1568997223002331"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103499","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103499"}}